Vedolizumab improves mucosal healing in IBD patients who failed anti-TNF therapy

1408 Views

eMediNexus 18 February 2018

Results from an observational multicenter study presented February 15, 2018 at the European Crohns and Colitis Organisation 2018 Congress in Vienna shows that vedolizumab improves mucosal healing in people with Crohns disease and ulcerative colitis who failed or became intolerant to previous anti-tumor necrosis factor (TNF) therapy.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.